Edition:
United States

Opexa Therapeutics Inc (OPXA.PH)

OPXA.PH on Philadelphia Stock Exchange

0.93USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$0.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,755
52-wk High
$4.82
52-wk Low
$0.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.26 December 2 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 4 4 4
(3) HOLD 4 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 4 0.73 0.76 0.70 0.51
Quarter Ending Mar-17 3 0.43 1.30 0.00 5.75
Year Ending Dec-16 4 2.91 2.95 2.90 2.28
Year Ending Dec-17 4 14.48 27.91 0.00 25.00
Earnings (per share)
Quarter Ending Dec-16 4 -0.26 -0.18 -0.33 -0.39
Quarter Ending Mar-17 3 -0.32 -0.19 -0.51 --
Year Ending Dec-16 4 -1.12 -0.96 -1.25 -4.20
Year Ending Dec-17 4 -0.06 1.71 -2.21 1.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 0.72 0.73 0.00 0.37
Quarter Ending Jun-16 0.72 0.73 0.00 0.51
Quarter Ending Mar-16 0.40 0.73 0.33 81.50
Quarter Ending Sep-15 0.51 0.73 0.22 42.72
Quarter Ending Jun-15 0.00 0.73 0.73 0.00
Earnings (per share)
Quarter Ending Sep-16 -0.25 -0.28 0.03 -10.89
Quarter Ending Jun-16 -0.23 -0.30 0.07 -28.59
Quarter Ending Mar-16 -0.35 -0.31 0.04 -11.43
Quarter Ending Dec-15 -0.50 -0.30 0.20 -40.00
Quarter Ending Sep-15 -1.81 -0.42 1.39 -76.84

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 0.73 0.73 0.73 0.73 0.51
Quarter Ending Mar-17 0.43 0.43 0.43 0.43 5.75
Year Ending Dec-16 2.91 2.91 2.91 2.91 2.28
Year Ending Dec-17 14.48 14.48 14.48 14.48 25.00
Earnings (per share)
Quarter Ending Dec-16 -0.26 -0.26 -0.26 -0.26 -0.39
Quarter Ending Mar-17 -0.32 -0.32 -0.32 -0.32 --
Year Ending Dec-16 -1.12 -1.12 -1.12 -1.12 -4.20
Year Ending Dec-17 -0.06 -0.06 -0.06 -0.06 1.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 0 0
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Dec-16 0 0 0 0
Quarter Ending Mar-17 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0